Search

everythinglearnresearchcommunity

for

Search:↓

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

The meeting presented new findings on hair stem cells, pigmentation, genetics, and modern hair treatment techniques.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

Topical Imiquimod may fight vascular tumors by affecting blood vessels or the immune system, low iron might be linked to some hair loss, removing the top skin layer helps vitamin C get in, genetic testing helps diagnose skin conditions, and too much iron could worsen skin inflammation.

A woman's eyelashes grew thicker and longer after taking topiramate, but returned to normal when she stopped the medication.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

COVID-19 infection may trigger alopecia areata in some patients.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Mesenchymal stem cells in people with Hidradenitis Suppurativa are more inflammatory, possibly contributing to the disease.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

A man with skin and hair symptoms improved partially with specific treatment.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Rodent models helped understand psoriasis but none perfectly replicated the disease.

Finasteride can cause a unique skin reaction on the penile shaft.

New drug delivery systems improve treatment effectiveness and patient experience.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Fixing DNA errors is crucial to prevent skin cancer.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

A patient developed hair loss after hepatitis C treatment with sofosbuvir and ribavirin.

COVID-toes show a unique immune response over time, different from vaccine-related chilblains.